Back to today’s briefing

Story perspectives

Kodak Faces Debt Woes, Shifts to Pharma Production

8/12/2025

45 10

Summary

Story summary

Eastman Kodak Co. expresses concerns about potential debt issues but is optimistic about fulfilling obligations.
As of June 30, the company reported $155 million in cash reserves.
Kodak aims to reduce its debt significantly and amend remaining commitments.
The company is shifting towards pharmaceutical manufacturing, with production anticipated to begin later this year.
Shares dropped by over 25% due to these financial concerns.

1 of 1

Story summary

Eastman Kodak Co. expresses concerns about potential debt issues but is optimistic about fulfilling obligations.
As of June 30, the company reported $155 million in cash reserves.
Kodak aims to reduce its debt significantly and amend remaining commitments.
The company is shifting towards pharmaceutical manufacturing, with production anticipated to begin later this year.
Shares dropped by over 25% due to these financial concerns.